Mrs Tina Snow, LAMFT | |
2201 S Avenue A, #102, Yuma, AZ 85364-8459 | |
(928) 276-9535 | |
Not Available |
Full Name | Mrs Tina Snow |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 2201 S Avenue A, Yuma, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275926354 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | LAMFT-5575T (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Tina Snow, LAMFT 2201 S Avenue A, #102, Yuma, AZ 85364-8459 Ph: (928) 276-9535 | Mrs Tina Snow, LAMFT 2201 S Avenue A, #102, Yuma, AZ 85364-8459 Ph: (928) 276-9535 |
News Archive
Kamada (TASE:KMDA), a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has entered into an exclusive agreement with a large US specialty pharmaceutical distributor company for the distribution of its flagship product, intravenous alpha-1 antitrypsin (AAT-IV) in the United States.
Researchers in Calgary have launched the first gene therapy clinical trial in the world for Fabry disease, a rare inherited enzyme deficiency that can shorten the lifespan of people who have it by as much as 40 years.
The Second Annual Science Writers Symposium on Nov. 4 and 5, 2009, at the FDA's White Oak campus in Silver Spring, Md., will highlight how the FDA applies novel scientific approaches to critical public health issues and the products it regulates. The symposium, featuring a lab tour and presentations by FDA scientists, will give writers a unique insight into the evolving field of regulatory science with an eye towards generating potential story ideas.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has classified the BYDUREON™ (exenatide for extended-release injectable suspension) complete response as a Class 2 resubmission and assigned a new Prescription Drug User Fee Act (PDUFA) action date of October 22, 2010.
In a large study, 38% of 491 testicular cancer survivors had low testosterone levels, known as hypogonadism.
› Verified 1 days ago
Ms. Josephina Camacho Garcia, MA Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 281 W 24th St # 139, Yuma, AZ 85364 Phone: 928-581-4911 | |
Claudia Maria Lara, LAMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 256 S 2nd Ave Ste G, Yuma, AZ 85364 Phone: 928-256-5670 Fax: 928-248-4370 | |
Richard Smith, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2201 S Avenue A, Yuma, AZ 85364 Phone: 928-269-2561 | |
Paulina Sanchez, MS, BHT, CCST-I Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1185 S Redondo Center Dr Ste 1, Yuma, AZ 85365 Phone: 928-414-7037 Fax: 317-520-8200 |